MapHospitals
Oncoplus Super Speciality Hospital

Oncoplus Super Speciality Hosp...

New Delhi
VS
Rajiv Gandhi Cancer Institute and Research Center, Niti Bagh, South Delhi

Rajiv Gandhi Cancer Institute...

New Delhi
Feature Oncoplus Super Speciality Ho... Rajiv Gandhi Cancer Institut...
Verified No No
Rating
(0 reviews)
(0 reviews)
City New Delhi New Delhi
Address B-73 & B-75, Bhishma Pitamah Marg, Block B, Defence Colony, New Delhi, Delhi 110024, India Squadron Leader Mohinder Kumar Jain Marg, South Extension II, Block K, Neeti Bagh, New Delhi, Delhi 110049, India
Enquiries 0 0
Phone +91 85889 09091 +91 11 4582 222
Specialities Count 1 2
Website Visit Visit
Specialities
Otorhinolaryngology
Oncology Otorhinolaryngology

Shared (1)

Otorhinolaryngology

Only at Rajiv Gandhi Cancer Insti...

Oncology

Oncoplus Super Speciality Hospital vs Rajiv Gandhi Cancer Institute and Research Center, Niti Bagh, South Delhi: Detailed Comparison

Choosing the right hospital is a critical decision for patients seeking quality healthcare. Oncoplus Super Speciality Hospital, located in New Delhi, offers 1 medical specialities . Meanwhile, Rajiv Gandhi Cancer Institute and Research Center, Niti Bagh, South Delhi in New Delhi provides 2 specialities .

Both hospitals share 1 common speciality, including Otorhinolaryngology. This means patients looking for Otorhinolaryngology can consider either hospital based on location, reviews, and other preferences.

Rajiv Gandhi Cancer Institute and Research Center, Niti Bagh, South Delhi stands out with Oncology.

For detailed information, visit the individual hospital pages: Oncoplus Super Speciality Hospital or Rajiv Gandhi Cancer Institute and Research Center, Niti Bagh, South Delhi. You can also use our hospital comparison tool to compare up to 3 hospitals side by side.

Get Free Consultation

We'll connect you with the right hospital

Your Details Treatment Info

Secure Reply in 24h No spam
hospital(s) selected
Compare Now
We use cookies and analytics to improve your experience. By continuing to browse, you consent to our use of cookies. Privacy Policy